DocWire News Editors

DocwireNews

A study looking into technology&rsquo;s role in cancer patient management is set to be conducted at the Haga Teaching Hospital in the Netherlands. The researchers will be using VitalPatch, a product created by Vital Connect that can detect 8 vital signs including heart rate, respiratory rate, skin temperature, posture, activity, patient falling, and provides ECG monitoring. Vital Connect has teamed up with physIQ for this study to utilize their product pinpointIQ, the only FDA approved analytics software to detect subtle deviations in vitals from the patients baseline data. Just last year, physIQ received $8 million in series B funding, bringing the companies value up to $19.9 million.Patients in the study will wear the VitalPatch continuously, with their physiological information being captured with pinpointIQ. The patients will either be treated via erythrocyte transfusion or chemotherapy, with some patients going through immunotherapy. Researchers will give them the patch prior to treatment, allowing the pinpointIQ AI to set baseline readings for each patient. From the VitalPatch&rsquo;s readings given during and after treatment, researchers will analyze how patients respond throughout stages of each treatment. Financed by Janssen Pharmaceuticals, this study will hopefully provide data that assists physicians in properly handling complications associated with treatment.&ldquo;By monitoring patients this way, we hope to identify a novel approach to proactively identifying and managing adverse events that may otherwise negatively impact patient outcomes,&rdquo; says Dr. Martin Schipperus, hematologist at Haga Teaching Hospital.Vital Connect technology has been researched in previous studies as well, with their HealthPatch MD being found to identify hypoglycemic events in diabetics via heart rate in a study conducted this March. The VitalPatch and pinpointIQ have both already been used by multiple health care providers and hospitals as well.Both companies have also begun collaborating on an initiative involving home patient care, with the goal of reducing hospitalizations for common medical issues. The first phase of this study began in September of 2016 and involved 30 patients receiving traditional hospital care and 30 receiving home treatment utilizing VitalPatch and physIQ software. The companies plan to expand cohort size in similar studies to compare the efficacy of their technology to in-hospital care.<iframe loading="lazy" src="https://www.youtube.com/embed/cgmePTvAqPM" width="854" height="480" frameborder="0" allowfullscreen="allowfullscreen"></iframe>Sources: <a href="https://www.mobihealthnews.com/content/janssen-funds-cancer-study-using-vital-connect-physiq-tech">Mobi Health News</a>, <a href="http://www.physiq.com/press-media/physiq-and-vital-connect-collaborate-to-deliver-home-hospital-pilot-initiative-for-patients-admitted-to-home/">physIQ</a>, <a href="https://vitalconnect.com/solutions/vitalpatch/">VitalConnect</a>

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Using Wireless Biosensor in Studying Cancer Treatments

Future of Medicine

A study looking into technology’s role in cancer patient management is set to be conducted at the Haga Teaching Hospital in the Netherlands. The researchers will be using ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe